Overview of Assets
Our Assets give investors access to life sciences businesses with unique exposure across diverse modalities, therapeutic areas and geographies.
Our assets are largely maturing clinical development or commercial companies, nearing significant value inflection or realisation points, in which we hold meaningful stakes.
Our Assets
Our strategic objective is to support value creation in our investee companies.
We offer investors access to companies with compelling value propositions spanning innovation across multiple areas of healthcare. Our investee companies are at the forefront of cutting-edge technological advancement in their fields and have the required talent and technical expertise to deliver profound healthcare improvements to patients around the world.
4 Growth Potential Assets
We will continue to support the progression of these assets as they target important strategic, scientific and operational milestones.
Early-stage assets
Revenue generative assets
Latest investee company news
Stay up to date
Sign up to Malin news alerts so you never miss a key company update.